Tomocube, Inc (475960) Fair Value & Analysis
Healthcare · KR · Market cap 498B KRW
Fair value as of: Jun 24, 2026
Analysis
Tomocube, Inc (475960) currently trades at 36,550 KRW, while our model-based Fair Value estimate is 8,781 KRW — implying the stock looks roughly 76.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibration isolation system that enables users to capture images in a stable environment; and vessel holders, environmental controllers, and 3D controllers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Tomocube, Inc (475960) undervalued?
What is the fair value of 475960?
What is the quality score of 475960?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.